NCVLX
Price
$12.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VMVAX
Price
$88.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

NCVLX vs VMVAX

Header iconNCVLX vs VMVAX Comparison
Open Charts NCVLX vs VMVAXBanner chart's image
Nuance Concentrated Value Institutional
Price$12.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$88.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
NCVLX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NCVLX vs. VMVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCVLX is a Buy and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. NCVLX (172M). VMVAX pays higher dividends than NCVLX: VMVAX (2.14) vs NCVLX (1.75). NCVLX was incepted earlier than VMVAX: NCVLX (13 years) vs VMVAX (13 years). NCVLX is a more actively managed with annual turnover of: 67.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than NCVLX: VMVAX (3000) vs NCVLX (10000). VMVAX annual gain was more profitable for investors over the last year : 28.30 vs. NCVLX (14.55). VMVAX return over 5 years is better than : 48.86 vs. NCVLX (-10.18).
NCVLXVMVAXNCVLX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD3.75318.47620%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets172M30.9B1%
Annual Yield % from dividends1.752.1482%
Returns for 1 year14.5528.3051%
Returns for 3 years-17.9514.98-120%
Returns for 5 years-10.1848.86-21%
Returns for 10 years-1.32100.72-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U19.13-0.09
-0.47%
Unity Software
MP19.12-0.73
-3.68%
MP Materials Corp
MLAB107.79-4.62
-4.11%
Mesa Laboratories
TTNP4.15-0.26
-6.00%
Titan Pharmaceuticals
LPTX2.99-0.25
-7.85%
Leap Therapeutics